Page 33 - JCTR-10-5

Omrani et al.| Journal of Clinical and Translational Research 2024; 10(5): 291-295 295
2020;11:594556. doi: 10.1111/j.1651-2227.1986.tb10254.x
doi: 10.3389/fimmu.2020.594556 [14] Alanko S, Salmi TT, Pelliniemi TT. Recovery of Blood
[6] Nazari S. Mechanical Events in Physiopathology of T-Cell Subsets after Chemotherapy for Childhood Acute
Idiopathic Pulmonary Emphysema: A Theoretical Lymphoblastic Leukemia. Pediatr Hematol Oncol
Analysis. Internet J Thorac Cardiovasc Surg 2002;5: 1-17. 1994;11:281-92.
[7] Crawford J, Dale DC, Lyman GH. Chemotherapy- doi: 10.3109/08880019409141671
induced Neutropenia: Risks, Consequences, and New [15] Leadman D, Xu Y, Qu S, Zhu Q, editors. Integrative
Directions for Its Management. Cancer 2004;100:228-37. Rare Disease Profile Creation Via NormMap to Advance
doi: 10.1002/cncr.11882 Rare Disease Research. In: 2022 IEEE International
[8] Perkins JL, Harris A, Pozos TC. Immune Dysfunction Conference on Bioinformatics and Biomedicine (BIBM).
After Completion of Childhood Leukemia Therapy. Las Vegas: IEEE; 2022.
J Pediatr Hematol Oncol 2017;39:1-5. doi: 10.1109/BIBM55620.2022.9995172
doi: 10.1097/MPH.0000000000000697 [16] Lehrnbecher T, Foster C, Vázquez N, Mackall CL,
[9] Layward L, Levinsky RJ, Butler M. Long-term Chanock SJ. Therapy-Induced Alterations in Host Defense
Abnormalities in T and B Lymphocyte Function in in Children Receiving Therapy for Cancer. Journal of
Children Following Treatment for Acute Lymphoblastic Pediatric Hematology Oncology 1997;19(5):399-417.
Leukaemia. Br J Haematol 1981;49:251-8. doi: 10.1097/00043426-199709000-00001
doi: 10.1111/j.1365-2141.1981.tb07221.x [17] Ek T, Mellander L, Andersson B, Abrahamsson J. Immune
[10] Caver TE, Slobod KS, Flynn PM, Behm FG, Reconstitution after Childhood Acute Lymphoblastic
Hudson MM, Turner EV, et al. Profound Abnormality Leukemia is Most Severely Affected in the High Risk
of the B/T Lymphocyte Ratio During Chemotherapy for Group. Pediatr Blood Cancer 2005;44(5):461-8.
Pediatric Acute Lymphoblastic Leukemia. Leukemia doi: 10.1002/pbc.20255
1998;12(4):619-22. [18] Williams AP, Bate J, Brooks R, Chisholm J, Clarke SC,
doi: 10.1038/sj.leu.2400970 Dixon E, et al. Immune Reconstitution in Children
[11] Ito C, Evans WE, McNinch L, Coustan-Smith E, Following Chemotherapy for Acute Leukemia. EJHaem
Mahmoud H, Pui CH, et al. Comparative Cytotoxicity 2020;1(1):142-51.
of Dexamethasone and Prednisolone in Childhood Acute doi: 10.1002/jha2.27
Lymphoblastic Leukemia. J Clin Oncol 1996;14(8):2370-6. [19] Kosmidis S, Baka M, Bouhoutsou D, Doganis D,
doi: 10.1200/JCO.1996.14.8.2370 Kallergi C, Douladiris N, et al. Longitudinal Assessment
[12] Kung FH, Orgel HA, Wallace WW, Hamburger RN. of Immunological Status and Rate of Immune Recovery
Antibody Production Following Immunization with Following Treatment in Children with ALL. Pediatr
Diphtheria and Tetanus Toxoids in Children Receiving Blood Cancer 2008;50(3):528-32.
Chemotherapy During Remission of Malignant Disease. doi: 10.1002/pbc.21327
Pediatrics 1984;74(1):86-9. [20] Ibáñez IM, Casas AA, Martinez OC, Aguado JE,
[13] Rautonen J, Siimes MA, Lundström U, Pettay O, Mateos MM. Humoral Immunity in Pediatric Patients
Lanning M, Salmi TT, et al. Vaccination of Children with Acute Lymphoblastic Leukaemia. Allergol
During Treatment for Leukemia. Acta Pædiatr Scand Immunopathol (Madr) 2003;31(6):303-10.
1986;75(4):579-85. doi: 10.1016/s0301-0546(03)79203-9

Publisher’s note
AccScience Publishing remains neutral with regard to
jurisdictional claims in published maps and institutional
affiliations.

DOI: http://doi.org/10.36922/jctr.24.00050